Plataforma para el análisis de ARN, ADN o proteínas como biomarcadores en el diagnóstico, pronóstico y evaluación de tratamientos
Abstract
In order to evaluate the nCounter® technology, a systematic literature review was conducted in the Pubmed database in the period between 2015 and March 2021. The purpose of this systematic review was to identify diagnostic, prognostic and treatment studies in patients with oncological and non-oncological indications of any age in which
nCounter® technology was compared to other existing techniques (immunohistochemistry, FISH, RT-qPCR, RTPCR, among others). The study designs were systematic reviews, randomised clinical trials, observational studies (of diagnostic tests, among others) and economic evaluations.
Keywords
Biomarkers; Diagnosis; Treatment evaluation
Bibliographic citation
Gallastegui Calvache E, Segur Ferrer J. Plataforma para el análisis de ARN, ADN o proteínas como biomarcadores en el diagnóstico, pronóstico y evaluación de tratamientos. Barcelona: Agència de Qualitat i Avaluació Sanitàries de Catalunya; 2021. (Informes de evaluación de tecnologías sanitarias).
Audience
Professionals
Use this identifier for quote and/or link this document
https://hdl.handle.net/11351/7609This item appears in following collections
The following license files are associated with this item: